FDA Warns That Thermal Imaging Systems Pose a Potential Danger to Public Health

The U.S. Food and Drug Administration (FDA) announced that improper use of thermal imaging systems that measure human body temperature, also known as thermal cameras, may provide inaccurate and unreliable temperature readings. Additionally, the FDA issued Warning Letters to certain firms offering unapproved, uncleared, and unauthorized thermal imaging systems for sale. During the pandemic, non-contact thermal imaging have been used broadly when screening for fever, the #1 COVID-19 symptom. These public screenings have persisted in spite of a large body of scientific research proving their ineffectiveness in obtaining accurate temperature readings.

You May Also Be Interested In

• Mainz Biomed (MYNZ) Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm
• Biogen (BIIB) Receives Positive CHMP Opinion for TOFIDENCE
• Capricor Therapeutics (CAPR) Announces Positive Type-B Meeting with FDA for CAP-1002